Resource utilization and therapy costs for patients with advanced stage IIIB/IV non-small cell lung cancer. Retrospective data from patients participating in the erlotinib phase IV study (TRUST) in Finland: P1-261
Journal of Thoracic Oncology（2007）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要